Shares of Niagen Bioscience (NAGE) are soaring 6.25% in pre-market trading on Thursday, following the company's announcement of a $10 million share repurchase program. This significant uptick reflects investors' positive reaction to the buyback initiative, which was revealed early Thursday morning.

The share repurchase program demonstrates Niagen Bioscience's confidence in its financial position and future prospects. Such programs are often viewed favorably by the market as they can potentially increase earnings per share and signal that management believes the stock is undervalued. This move is likely to provide support for Niagen Bioscience's stock price in the near term.

Analysts suggest that this strategic decision by Niagen Bioscience could be interpreted as a bullish signal for the company's future performance. As the market opens, it remains to be seen how this momentum will carry through the regular trading session. Investors are advised to consider the company's overall financial health and growth strategy when evaluating the long-term implications of this buyback program.